Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Oropharyngeal cancer
Stage/Subtype:  stage I oropharyngeal cancer
Country:  U.S.A.
Trial Type:  Treatment
Results 1-17 of 17 for your search:
Start Over
Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients with Stage III-IV Oropharyngeal Cancer
Phase: Phase III, Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2012-0825, NCI-2013-01879, NCT01893307
Vaccine Therapy and Cyclophosphamide in Treating Patients with Pancreatic Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: J09100, NCI-2010-01868, CIR00005394, NA_00031401, NCT01088789
Intensity-Modulated Radiation Therapy in Treating Patients With Cancer of the Oropharynx
Phase: Phase II
Type: Natural history/Epidemiology, Treatment
Age: 18 and over
Trial IDs: J0988, NCI-2009-01536, NCT01088802
Docetaxel, Cisplatin, and Cetuximab in Treating Patients With Metastatic or Relapsed Head and Neck Cancer
Phase: Phase II
Type: Treatment
Age: 16 and over
Trial IDs: ENT0033, NCI-2011-03271, 22329, SU-08222011-8290, NCT01437449
Radiation Therapy and Cisplatin in Treating Patients With Low-Risk HPV-Related Oropharyngeal Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: LCCC 1120, NCI-2013-01074, 11-1557, NCT01530997
Tadalafil in Treating Patients With Head and Neck Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 21 and over
Trial IDs: J1247, NCI-2012-02047, CIR00001158, NA_00073880, NCT01697800
Radiation Therapy and Docetaxel in Treating Patients with HPV-Related Oropharyngeal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MC1273, NCI-2013-01652, 12-005272, NCT01932697
Azacitidine in Measuring Tumor Response in Patients with HPV Positive or Negative Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 1404013771, NCI-2015-01437, 200 FR. 4 (2012-1), NCT02178072
Transoral Robotic Surgery and Adjuvant Therapy in Treating Patients with HPV-Positive Oropharyngeal Cancer That Can Be Removed by Surgery
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2013-0925, NCI-2014-02126, NCT02225496
Intensity-Modulated Radiation Therapy and Chemotherapy in Treating Patients with Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: LCCC 1413, NCI-2014-02348, 14-1795, NCT02281955
Surgery with or without Stereotactic Body Radiotherapy in Treating Patients with Previously-Irradiated Head and Neck Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 14-151, NCI-2015-01424, NCT02516969
Dexamethasone in Reducing Oral Pain and Dry Mouth after Surgery in Patients with Oropharyngeal Cancer
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 andover
Trial IDs: 8071, NCI-2012-02780, CPC-12095-L, CR00021919, NCT01748942
Transoral Robotic Surgery in Treating Patients with Oropharyngeal or Supraglottic Squamous Cell Carcinoma
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: SCCA-TORS-2012, NCI-2013-01936, 16376, NCT01819480
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 229812, NCI-2013-01198, NCT01896778
Ganetespib before Surgery in Treating Patients with Stage I-IVA Squamous Cell Carcinoma of the Head and Neck That Can Be Removed by Surgery
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 to 79
Trial IDs: WINSHIP2572-13, NCI-2014-02605, NCT02334319
Transoral Robotic Surgery in Treating Patients With Oropharyngeal, Hypopharyngeal, and Oral Cavity Cancer
Phase: No phase specified
Type: Treatment
Age: 20 and over
Trial IDs: HNO 0601, NCI-2011-03028, NCT00473564
Start Over